Neil Gorsuch & Bayer
1 shared events · Importance 4 · Last updated Jun 25, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
Neil Gorsuch: Joined Jackson's dissent, opposing the majority's preemption ruling.
Bayer: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.
Jun 25, 2026 · 133 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Neil Gorsuch and Bayer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard